Oppenheimer Analysts Reduce Earnings Estimates for CME Group Inc. (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) – Investment analysts at Oppenheimer cut their Q4 2022 earnings per share (EPS) estimates for CME Group in a research note issued on Thursday, January 13th. Oppenheimer analyst O. Lau now expects that the financial services provider will post earnings of $1.76 per share for the quarter, down from their previous forecast of $1.83.

A number of other equities research analysts have also weighed in on CME. Morgan Stanley boosted their price target on CME Group from $217.00 to $234.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 28th. Piper Sandler restated a “buy” rating and set a $230.00 price target on shares of CME Group in a research note on Friday, October 1st. Rosenblatt Securities boosted their price target on CME Group from $194.00 to $197.00 and gave the stock a “sell” rating in a research note on Thursday, October 28th. Deutsche Bank Aktiengesellschaft boosted their price target on CME Group from $230.00 to $235.00 in a research note on Thursday. Finally, TheStreet upgraded CME Group from a “c+” rating to a “b” rating in a research report on Wednesday, October 27th. Two analysts have rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $228.82.

Shares of CME Group stock opened at $223.19 on Friday. CME Group has a one year low of $177.73 and a one year high of $232.64. The company has a market capitalization of $80.21 billion, a PE ratio of 32.92, a P/E/G ratio of 6.24 and a beta of 0.46. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01. The company has a 50-day simple moving average of $225.94 and a two-hundred day simple moving average of $212.43.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 27th. The financial services provider reported $1.60 EPS for the quarter, topping the Zacks’ consensus estimate of $1.55 by $0.05. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.15 billion. CME Group had a net margin of 52.47% and a return on equity of 8.60%. The firm’s revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.38 earnings per share.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Benjamin Edwards Inc. raised its stake in CME Group by 3,500.0% in the 3rd quarter. Benjamin Edwards Inc. now owns 216 shares of the financial services provider’s stock valued at $42,000 after purchasing an additional 210 shares during the last quarter. Hilton Capital Management LLC acquired a new position in CME Group in the 3rd quarter valued at $50,000. RE Advisers Corp raised its stake in CME Group by 53.1% in the 3rd quarter. RE Advisers Corp now owns 271 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 94 shares during the last quarter. First Horizon Advisors Inc. raised its stake in CME Group by 96.7% in the 3rd quarter. First Horizon Advisors Inc. now owns 417 shares of the financial services provider’s stock valued at $69,000 after purchasing an additional 205 shares during the last quarter. Finally, Consolidated Planning Corp acquired a new position in CME Group in the 3rd quarter valued at $87,000. 84.92% of the stock is owned by hedge funds and other institutional investors.

In other news, insider Hilda Harris Piell sold 2,947 shares of the company’s stock in a transaction that occurred on Tuesday, October 19th. The stock was sold at an average price of $215.00, for a total transaction of $633,605.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ken Vroman sold 445 shares of the company’s stock in a transaction that occurred on Tuesday, November 9th. The stock was sold at an average price of $220.00, for a total value of $97,900.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 24,492 shares of company stock valued at $5,434,355. Corporate insiders own 0.30% of the company’s stock.

The business also recently declared a None dividend, which was paid on Friday, January 14th. Shareholders of record on Tuesday, December 28th were issued a $3.25 dividend. The ex-dividend date of this dividend was Monday, December 27th. This is an increase from CME Group’s previous None dividend of $2.50. CME Group’s payout ratio is presently 53.10%.

CME Group Company Profile

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Read More: What are the advantages of the Stochastic Momentum Index?

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.